Goldman Sachs
TENX icon

Goldman Sachs’s Tenax Therapeutics TENX Stock Holding History

Goldman Sachs’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4M Buy
274,946
+243,092
+763% +$3.11M ﹤0.01% 4084
2026
Q1 		$509K Buy
31,854
+9,445
+42% +$128K ﹤0.01% 5583
2025
Q4 		$273K Buy
+22,409
New +$195K ﹤0.01% 5909
2020
Q3 		– Sell
-14
Closed -$20K – 5535
2020
Q2 		$20K Buy
+14
New +$20.6K ﹤0.01% 5127
2016
Q2 		– Sell
-1
Closed -$54K – 7251
2016
Q1 		$54K Hold
1
– – ﹤0.01% 6387
2015
Q4 		$84K Hold
1
– – ﹤0.01% 6276
2015
Q3 		$64K Hold
1
– – ﹤0.01% 6688
2015
Q2 		$79K Hold
1
– – ﹤0.01% 6719
2015
Q1 		$73K Hold
1
– – ﹤0.01% 6566
2014
Q4 		$136K Sell
1
-1
-50% -$121K ﹤0.01% 6422
2014
Q3 		$190K Buy
+2
New +$257K ﹤0.01% 6210

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Goldman Sachs's TENX Position: Q2 2026 in Review

Goldman Sachs increased its Tenax Therapeutics (TENX) stake by 763% in Q2 2026, buying an estimated $3.11M and bringing the position to 274,946 shares worth $4M. The position accounts for ﹤0.01% of the portfolio, ranked #4084.

Goldman Sachs first reported a position in TENX in Q3 2014 and has held it in 11 quarters since. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Goldman Sachs held 274,946 shares of Tenax Therapeutics worth $4M as of Q2 2026.
  • Goldman Sachs bought 243,092 Tenax Therapeutics shares in Q2 2026, an estimated $3.11M.
  • Tenax Therapeutics made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4084 holding.
  • Goldman Sachs first reported a position in Tenax Therapeutics in Q3 2014 and has held it in 11 quarters since.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.